0000890465-13-000037.txt : 20131226
0000890465-13-000037.hdr.sgml : 20131225
20131226173605
ACCESSION NUMBER: 0000890465-13-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131223
FILED AS OF DATE: 20131226
DATE AS OF CHANGE: 20131226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRONINGER JAMES G
CENTRAL INDEX KEY: 0001013420
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 131299185
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
STREET 2: 3RD FLOOR
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-12-23
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001013420
GRONINGER JAMES G
550 HILLS DRIVE
BEDMINSTER
NJ
07921
1
0
0
0
Common Stock
2013-12-23
4
M
0
3000
21.73
A
3750
D
Common Stock
2013-12-23
4
S
0
3000
29.50
D
750
D
Stock Options
21.73
2013-12-23
4
M
0
3000
0
D
2014-05-20
Common Stock
3000
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 10, 2013
On May 20, 2004, the Reporting Person received a grant of 3,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the date of grant and 2% each month thereafter. As of the date of this filing, 3,000 stock options have vested.
/s/James Groninger, by Edward Stratemeier as attorney-in-fact
2013-12-26